[go: up one dir, main page]

PL3438096T3 - Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu - Google Patents

Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu

Info

Publication number
PL3438096T3
PL3438096T3 PL17773281T PL17773281T PL3438096T3 PL 3438096 T3 PL3438096 T3 PL 3438096T3 PL 17773281 T PL17773281 T PL 17773281T PL 17773281 T PL17773281 T PL 17773281T PL 3438096 T3 PL3438096 T3 PL 3438096T3
Authority
PL
Poland
Prior art keywords
arylmethyl
quinazoline
dione
manufacturing process
manufacturing
Prior art date
Application number
PL17773281T
Other languages
English (en)
Inventor
Suixiong Cai
Ping Huang
Original Assignee
Impact Therapeutics, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Impact Therapeutics, Inc filed Critical Impact Therapeutics, Inc
Publication of PL3438096T3 publication Critical patent/PL3438096T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL17773281T 2016-04-01 2017-03-31 Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu PL3438096T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610202881 2016-04-01
PCT/CN2017/078913 WO2017167251A1 (zh) 2016-04-01 2017-03-31 1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮的制备工艺
EP17773281.5A EP3438096B1 (en) 2016-04-01 2017-03-31 Manufacturing process for 1-(arylmethyl) quinazoline-2,4 (1h, 3h)-dione

Publications (1)

Publication Number Publication Date
PL3438096T3 true PL3438096T3 (pl) 2021-05-17

Family

ID=59963547

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17773281T PL3438096T3 (pl) 2016-04-01 2017-03-31 Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu

Country Status (13)

Country Link
US (1) US10562889B2 (pl)
EP (1) EP3438096B1 (pl)
CN (1) CN109153652B (pl)
CY (1) CY1123898T1 (pl)
DK (1) DK3438096T3 (pl)
ES (1) ES2859460T3 (pl)
HR (1) HRP20210328T1 (pl)
HU (1) HUE053554T2 (pl)
PL (1) PL3438096T3 (pl)
PT (1) PT3438096T (pl)
RS (1) RS61556B1 (pl)
SI (1) SI3438096T1 (pl)
WO (1) WO2017167251A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4185295A4 (en) * 2020-07-24 2024-07-24 Impact Therapeutics (Shanghai), Inc Combination therapy of parp inhibitors
WO2022099442A1 (zh) * 2020-11-10 2022-05-19 上海瑛派药业有限公司 5-氟-1-(4-氟-3-(4-(嘧啶-2-基)哌嗪-1-羰基)苄基)喹唑啉-2,4(1h,3h)-二酮的结晶形式及其制备

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087680A1 (en) * 2003-03-31 2004-10-14 Taisho Pharmaceutical Co., Ltd. Novel quinazoline derivatives and methods of treatment related to the use thereof
CN1980913B (zh) * 2004-06-30 2011-12-14 詹森药业有限公司 作为parp抑制剂的喹唑啉二酮衍生物
ATE435214T1 (de) * 2004-09-02 2009-07-15 Vertex Pharma Als ionenkanalmodulatoren geeignete chinazoline
CN101475537A (zh) * 2009-01-07 2009-07-08 太仓市浦源化工有限公司 一种2,4-二氯喹唑啉的制备方法
US9090568B2 (en) * 2011-03-14 2015-07-28 Impact Therapeutics, Inc. Quinazolinediones and their use
TWI527800B (zh) * 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚(二磷酸腺苷酸-核醣)聚合酶(parp)之抑制劑之1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮及其應用
US9102631B2 (en) * 2011-11-01 2015-08-11 Impact Therapeutics, Inc. 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
WO2016155655A1 (zh) * 2015-04-03 2016-10-06 上海瑛派药业有限公司 Parp抑制剂固体药物剂型及其应用
JP6375069B2 (ja) * 2015-12-21 2018-08-15 出光興産株式会社 ヘテロ原子で架橋されたフェニルキナゾリン

Also Published As

Publication number Publication date
HUE053554T2 (hu) 2021-07-28
EP3438096B1 (en) 2020-12-02
ES2859460T3 (es) 2021-10-04
CN109153652B (zh) 2021-07-27
PT3438096T (pt) 2021-03-03
RS61556B1 (sr) 2021-04-29
EP3438096A4 (en) 2019-08-21
DK3438096T3 (da) 2021-02-22
CN109153652A (zh) 2019-01-04
SI3438096T1 (sl) 2021-04-30
WO2017167251A1 (zh) 2017-10-05
US10562889B2 (en) 2020-02-18
US20190112298A1 (en) 2019-04-18
EP3438096A1 (en) 2019-02-06
CY1123898T1 (el) 2022-05-27
HRP20210328T1 (hr) 2021-04-02

Similar Documents

Publication Publication Date Title
GB2584931B (en) Textile and articles, and processes for making the same
ZA202004692B (en) Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
IL257442A (en) Process for preparing parp inhibitor, crystalline forms and their uses
PL3555074T3 (pl) Aminopirazole jako selektywne inhibitory kinaz janusowych
SI3227297T1 (sl) 4,6-substituirani-pirazolo(1,5-A)pirazini kot inhibitorji Janus kinaze
HK1246353A1 (zh) 產生苄基異喹啉生物碱(bia)前體的微生物及其製備和使用方法
PT3290418T (pt) Inibidores de janus quinase (jak)
LT3515990T (lt) Lignoceliuliozės ruošinių gamybos būdas
ZA202001250B (en) Improved process for preparing aminopyrimidine derivatives
HK1248699A1 (zh) 用於製備{1-(乙基磺酰基)-3-[4-(7h-吡咯並[2,3-d]嘧啶-4-基)-1h-吡唑-1-基]氮雜環丁烷-3-基}乙腈的方法和中間體
ZA202002530B (en) Process for producing herbicidal pyridazinone compounds
EP3349228A4 (en) ELECTROCONDUCTIVE POLYMER SOLUTION, CAPACITOR AND METHOD FOR PRODUCING CAPACITOR
IL248272A0 (en) A new manufacturing process for triazine, pyrimidine and pyridine derivatives
GB201621996D0 (en) Speakerphone configuration for conferencing
HUE053554T2 (hu) Eljárás 1-(arilmetil)-kinazolin-2,4-(1H, 3H)-dion elõállítására
ZA201805791B (en) 5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative
SMT202200434T1 (it) Processo di produzione di cellule t migliorato
EP3549935A4 (en) PROCESS FOR PRODUCING TRIAZINE COMPOUNDS
EP3554499A4 (en) AMINOPYRAZOLES AS JANUS KINASE INHIBITORS
EP3419627C0 (en) METHOD FOR PRODUCING ANTIVIRAL COMPOUNDS SUCH AS TRIAZAVIRIN
GB2572354B (en) Novel electrochemical set-up for ammonia production
ZA202004018B (en) Pallet block, pallet including same and process for obtaining same
SI3621966T1 (sl) Derivati pirazol(1,5-A)pirimidina kot kinazni JAK inhibitorji
EP3498688A4 (en) PROCESS FOR PREPARING N- (ALKOXYETHYL) FORMAMIDE